Cochrane · systematic review · CD003588

Optimal timing for intravascular administration set replacement

Ullman, AJ, Cooke, ML, Gillies, D, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library

Emergency and Critical CareAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 5 · 83.3%Moderate 1 · 16.7%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Primary analysis: less versus more frequent for intravenous administration set replacement

Population: patients with intravenous administration set replacement
6 questions
OutcomeEffectEvidenceStatus / GRADE
Catheter‐related BSI as defined using criteria specified by Maki 2006; Mermel 2009; and O'Grady 2002
Primary analysis: less vs more frequent
RR 1.06 [0.66, 1.68]8 studies · 1794 participantsLow
Downgraded: risk of bias, imprecision
Infusate‐related BSI as defined using criteria specified by O'Grady 2002
Primary analysis: less vs more frequent
RR 0.69 [0.31, 1.51]11 studies · 1847 participantsLow
Downgraded: risk of bias, imprecision
Infusate colonization any positive quantitative culture of infusate
Primary analysis: less vs more frequent
RR 1.15 [0.7, 1.86]8 studies · 1549 participantsLow
Downgraded: risk of bias, imprecision
Catheter colonization any positive semiquantitative or quantitative culture from the distal catheter segment
Primary analysis: less vs more frequent
RR 1.08 [0.94, 1.24]4 studies · 1448 participantsModerate
Downgraded: risk of bias
All‐cause BSI any positive blood culture drawn from a peripheral vein taken whilst the IVD is in situ, or within 48 hours of removal (O'Grady 2002)
Primary analysis: less vs more frequent
RR 0.82 [0.48, 1.4]6 studies · 2297 participantsLow
Downgraded: risk of bias, imprecision
Mortality
Primary analysis: less vs more frequent
RR 1.85 [1.01, 3.38]2 studies · 1355 participantsLow
Downgraded: risk of bias, indirectness